ArticleBJUI compass2021

Prognosis and safety of radium-223 with concurrent abiraterone acetate or enzalutamide use for metastatic castration-resistant prostate cancer: Real-world data of Japanese patients.

Yasuhide Miyoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.